The person behind ARLE Catalyst.

Serves as a fractional Chief Commercial Officer across a portfolio of early-stage MedTech and AI-enabled healthcare startups — leading Series A fundraising, building clinical advisory boards, and directing go-to-market and regulatory strategy through FDA submission. Actively partnering with additional founders navigating this same inflection point.

• Led Series A fundraising strategy and investor narratives across multiple ventures
• Aligned executive stakeholders and built go-to-market strategy with milestone pathways
• Built clinical advisory boards to strengthen investor and regulatory credibility

A decade leading commercialization across cardiac, neuromodulation, and structural heart — from launching the first new pain therapy indication in 22 years to building the digital strategy for neuromodulation. Partnered with the diabetes team on a strategic collaboration, scaled a 25-person therapy awareness team, built a 100-physician KOL network, and educated 3,000+ physicians across 23 countries.

• Launched a new therapy indication for the industry
• Built a diverse 100-physician KOL network
• Launched multiple newly acquired devices into 50+ countries using the Build-Launch-Scale model

Drove market share growth across a competitive medical device category.

• Grew market share 9% in a competitive device category
• Negotiated 7,500+ hospital letters of commitment
• Secured 19 Integrated Delivery Network (IDN) proposals

Delivered top-tier sales performance while driving operational efficiency.

• Top-5 account executive with 170 accounts
• Drove strategic sales growth for a newly launched partnership product